We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Basic View | Expanded View
 Showing 1-17 of 17 Articles
JAMA Patient Page  FREE
Amy E. Thompson, MD

A suntan or sunburn is a sign that skin has been damaged by ultraviolet (UV) rays.

Topics: sunburn; suntan
Viewpoint  FREE
Lance B. Becker, MD; Tom P. Aufderheide, MD; Robert Graham, MD

This Viewpoint introduces a newly released Institute of Medicine report describing many actions that stakeholders across the United States can take to improve outcomes from cardiac arrest.

Viewpoint  FREE
Robert B. Hackey, PhD; Erika L. May, BS
Includes: Supplemental Content

In light of the King v Burell decision, this Viewpoint urges state legislators to look at the options and data before they leap into state-based marketplaces as part of the Affordable Care Act program.

This study used data from the 2008-2012 American Community Survey to investigate the association between legalizing same-sex marriage in New York and changes in health insurance coverage.

Viewpoint  FREE
Simon F. Haeder, MA, MPA, MA; David L. Weimer, PhD; Dana B. Mukamel, PhD

This Viewpoint explains the concept of narrow networks and the Affordable Care Act.

Viewpoint  FREE
Michael J. Joyner, MD; Nigel Paneth, MD, MPH

This Viewpoint discusses the promise of personalized or precision medicine compared with its achievements to date.

Viewpoint  FREE
David Satcher, MD, PhD; Edward W. Hook III, MD; Eli Coleman, PhD
Includes: Supplemental Content

This Viewpoint discusses a framework for improving patient care and public sexual health.

Viewpoint  FREE
Lawrence O. Gostin, JD; Daniel Lucey, MD, MPH

This Viewpoint discusses the importance of a well-trained and well-prepared health workforce in controlling outbreaks such as Middle East respiratory syndrome.

Viewpoint  FREE
Timothy S. Naimi, MD, MPH; James F. Mosher, JD

This Viewpoint discusses regulatory and public health challenges related to the availability of powdered alcohol products.

Viewpoint  FREE
Huseyin Naci, PhD; John P. A. Ioannidis, MD, DSc

This Viewpoint describes research approaches to evaluating wellness interventions, such as hybrid study designs, large population cohorts and biobanks, and citizen scientists and social networks.

Topics: health; life style
Viewpoint  FREE
Jeffrey S. Crowley, MPH; Gregory R. Nevins, JD; Melanie Thompson, MD

This Viewpoint discusses the role the Americans with Disabilities Act could play in ensuring that persons with HIV/AIDS can access health care without stigma and discrimination.

Viewpoint  FREE
Michelle J. Bayefsky, BA; Katherine W. Saylor, MS; Benjamin E. Berkman, JD, MPH

Striking a balance between public health research based on residual newborn screening blood spots and preserving parental rights to consent their use is the focus of this Viewpoint.

Viewpoint  FREE
Matthew L. Goldman, MD, MS; Brigitta Spaeth-Rublee, MA; Harold Alan Pincus, MD

This Viewpoint discusses developing quality metrics in behavioral and general health care to encourage more cost-effective care and improve the status quo.

Viewpoint  FREE
Richard Glassock, MD; Pierre Delanaye, MD, PhD; Meguid El Nahas, MD, PhD, FRCP

This Viewpoint discusses the ramifications of using a glomerular filtration rate of less than 60 mL/min/1.73 m2 for patients of all ages and proteinuria (albuminuria) for chronic kidney disease classification.

Viewpoint  FREE
Andrew S. Levey, MD; Lesley A. Inker, MD, MS; Josef Coresh, MD, PhD

This Viewpoint asserts that current guidelines should not be changed to require age calibration for diagnosis and classification of chronic kidney disease.

Viewpoint  FREE
Darshak M. Sanghavi, MD; Patrick H. Conway, MD

This Viewpoint discusses whether financially rewarding reductions in 10-year predicted risk for atherosclerotic heart disease across a physician’s patient population is an effective model for value-based prevention.

Viewpoint  FREE
Josiah D. Rich, MD, MPH; Eli Y. Adashi, MD, MS

This Viewpoint examines federal and state syringe access policies in light of a recent HIV outbreak among injection drug users.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts